Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for ...
It can be detected using “traditional ambulatory glucose monitors,” he said. In fact, it was first identified and described before continuous glucose monitoring (CGM) was introduced in 1999. Detecting ...